Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ALMRAlamar Biosciences, Inc.

Nasdaq · CIK 0002104204
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3826 Laboratory Analytical Instruments
FY end1231
XBRL facts169

Identity from submissions API

NameAlamar Biosciences, Inc.
CIK0002104204
TickersALMR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3826 Laboratory Analytical Instruments
EIN364899036
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone510-626-9888
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
47071 BAYSIDE PARKWAY
FREMONT
CA
94538
CA
Mailing address
47071 BAYSIDE PARKWAY
FREMONT
CA
94538
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

66 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4/A xslF345X06/form4a-11192026_091152.xml 0002126944-26-000009 17716
2026-11-19 3/A xslF345X06/form3a-11192026_091128.xml 0002126944-26-000007 6166
2026-11-13 4 xslF345X06/form4-11142026_021118.xml 0001231919-26-001575 31333
2026-11-05 4 xslF345X06/form4-11052026_041101.xml 0001231919-26-001540 24833
2026-11-04 10-Q 10-Q 0001193125-26-445905 001-43235 261519734 34 15742544 1 1
2026-11-03 4 xslF345X06/form4-11032026_041117.xml 0001231919-26-001531 56878
2026-11-03 8-K 8-K 2.02,5.02,9.01 0001193125-26-445353 001-43235 261517474 34 674982 1 1
2026-10-29 4 xslF345X06/form4-10292026_081054.xml 0001231919-26-001508 50780
2026-10-27 4 xslF345X06/form4-10272026_041002.xml 0001231919-26-001501 50775
2026-10-23 4 xslF345X06/form4-10232026_111021.xml 0001231919-26-001497 57255
2026-10-21 4 xslF345X06/form4-10212026_071001.xml 0001231919-26-001485 44294
2026-10-19 4 xslF345X06/form4-10192026_081007.xml 0001231919-26-001469 37059
2026-10-14 144 xsl144X01/primary_doc.xml 0001231919-26-001458 001-43235 261461110 33 5240
2026-10-14 144 xsl144X01/primary_doc.xml 0001231919-26-001456 001-43235 261461100 33 4732
2026-10-14 144 xsl144X01/primary_doc.xml 0001231919-26-001455 001-43235 261461094 33 5808
2026-10-14 144 xsl144X01/primary_doc.xml 0001231919-26-001454 001-43235 261461087 33 5748
2026-09-16 4 xslF345X06/form4-09162026_080954.xml 0001823381-26-000014 7484
2026-09-16 3 xslF345X06/form3-09162026_080932.xml 0001823381-26-000012 8319
2026-09-03 4 xslF345X06/form4-09032026_080949.xml 0001222644-26-000004 7419
2026-09-03 3 xslF345X06/form3-09032026_080909.xml 0001222644-26-000002 8376
2026-09-01 8-K 8-K 5.02 0001193125-26-378360 001-43235 261350610 34 137686 1 1
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002126941-26-000007 005-95626 261274797 34 7378
2026-08-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002059127-26-000005 005-95626 261263912 34 27417
2026-08-11 10-Q 10-Q 0001193125-26-343003 001-43235 261260308 34 12517692 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342378 001-43235 261258483 34 640001 1 1
2026-07-15 8-K 8-K 8.01 0001193125-26-304736 001-43235 261177417 34 136835 1 1
2026-07-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001875620-26-000010 005-95626 261159926 34 16886
2026-07-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001862953-26-000003 005-95626 261147890 34 156641
2026-05-08 10-Q 10-Q 0001193125-26-213424 001-43235 26956197 34 9896449 1 1
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213379 001-43235 26956141 34 471219 1 1
2026-04-23 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-173780 005-95626 26888995 34 125865
2026-04-23 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001875620-26-000007 005-95626 26887376 34 45113
2026-04-22 4 xslF345X06/form4-04222026_080434.xml 0001231919-26-000392 55043
2026-04-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001252 333-294697 26876622 33 1753
2026-04-20 4 4 0001193125-26-164634 37048
2026-04-20 4 xslF345X06/form4-04212026_120444.xml 0001823563-26-000013 8039
2026-04-20 4 xslF345X06/form4-04212026_120458.xml 0001455312-26-000004 16912
2026-04-20 4 xslF345X06/form4-04212026_120426.xml 0002126704-26-000004 41983
2026-04-20 4 xslF345X06/form4-04212026_120439.xml 0002126944-26-000004 29739
2026-04-20 4 xslF345X06/form4-04212026_120453.xml 0002126941-26-000004 63115
2026-04-20 4 xslF345X06/form4-04212026_120457.xml 0001786386-26-000006 12162
2026-04-20 4 xslF345X06/form4-04212026_120442.xml 0001534166-26-000006 34119
2026-04-20 S-8 S-8 0001193125-26-164128 333-295193 26875555 33 245791 1 1
2026-04-20 8-K 8-K 5.03,8.01,9.01 0001193125-26-163921 001-43235 26875014 34 184433 1 1
2026-04-20 POS AM POS AM 0001193125-26-162823 333-294697 26873455 33 44305
2026-04-17 424B4 424B4 0001193125-26-161647 333-294697 26872078 33 8373704
2026-04-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001218 333-294697 26869299 33 1740
2026-04-16 3 3 0001193125-26-159904 19838
2026-04-16 3 xslF345X06/form3-04172026_010412.xml 0001231919-26-000375 28225
2026-04-16 3 xslF345X06/form3-04172026_010403.xml 0001455312-26-000002 12341
2026-04-16 3 xslF345X06/form3-04172026_010434.xml 0001304782-26-000002 8459
2026-04-16 3 xslF345X06/form3-04172026_010412.xml 0001823563-26-000011 9868
2026-04-16 3 xslF345X06/form3-04172026_010429.xml 0001534166-26-000004 18109
2026-04-16 3 xslF345X06/form3-04172026_010401.xml 0001786386-26-000004 9849
2026-04-16 3 xslF345X06/form3-04172026_010442.xml 0002126704-26-000002 18197
2026-04-16 3 xslF345X06/form3-04172026_010457.xml 0002126944-26-000002 15922
2026-04-16 3 xslF345X06/form3-04172026_010416.xml 0002126941-26-000002 24488
2026-04-16 S-1MEF S-1MEF 0001193125-26-159789 333-295116 26869084 33 189506 1 1
2026-04-16 CERT ALMR_8A_Cert_2104204.pdf 0001354457-26-000353 001-43235 26867080 34 178897
2026-04-16 S-1/A S-1/A 0001193125-26-158122 333-294697 26865929 33 8451848
2026-04-15 8-A12B 8-A12B 0001193125-26-156986 001-43235 26864159 34 13675
2026-04-13 S-1/A S-1/A 0001193125-26-151891 333-294697 26856355 33 14416185 1 1
2026-03-27 S-1 S-1 0001193125-26-129039 333-294697 26807469 33 13489783 1 1
2026-03-12 DRS/A filename1.htm 0001193125-26-104470 377-08929 26749137 33 6481393
2026-02-17 DRS/A filename1.htm 0001193125-26-054940 377-08929 26642918 33 3580499
2026-01-09 DRS filename1.htm 0001193125-26-009127 377-08929 26524072 33 4049237

Latest XBRL company facts

One latest value per concept from companyfacts (169 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 69.48M 2026-10-31 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
ffd NetFeeAmt NetFeeAmt USD 22,561.31 2026-04-20 S-8 2026-04-20 0001193125-26-164128
ffd TtlFeeAmt TtlFeeAmt USD 22,561.31 2026-04-20 S-8 2026-04-20 0001193125-26-164128
ffd TtlOfferingAmt TtlOfferingAmt USD 163.37M 2026-04-20 S-8 2026-04-20 0001193125-26-164128
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-20 S-8 2026-04-20 0001193125-26-164128
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-16 S-1MEF 2026-04-16 0001193125-26-159789
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 16.55M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 21.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 561,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 14.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 7.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -173,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 520.51M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.83M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AdvertisingExpense Advertising Expense USD 800,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213424
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213424
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 9.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap Assets Assets USD 378.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap AssetsCurrent Assets, Current USD 317.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 1.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 121.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 126.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 126.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 91.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 31,251 2026-04-19 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -47.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 457,000 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.78M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 363,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 235.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ConvertibleDebt Convertible Debt USD 56.50M 2026-01-08 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap CostOfRevenue Cost of Revenue USD 36.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 66.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 3.91M 2026-04-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap DeferredRevenue Deferred Revenue USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 53.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 117,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap GrossProfit Gross Profit USD 52.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -47.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 465,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 9.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 9.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -69,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 17.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 447,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InterestExpenseOperating InterestExpenseOperating USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InterestIncomeOperating Interest Income, Operating USD 4.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 563,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 16.48M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InventoryNet Inventory, Net USD 54.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 31.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 6.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.104 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 79.75M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 9.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 8.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 7.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 29.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap Liabilities Liabilities USD 74.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 378.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LiabilitiesCurrent Liabilities, Current USD 33.48M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap LongTermInvestments Long-term Investments USD 0 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 247.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -109.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -46.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -47.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingExpenses Operating Expenses USD 93.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -41.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 42.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.48M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 39.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.30M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343003
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 36.24M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 4.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.51M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -171,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -34,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 974,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -395,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 124.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 466,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 15.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 56.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 197.80M 2026-04-20 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 204.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 10.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 20.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 995,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 15.24M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap PropertyPlantAndEquipmentTransfersAndChanges Property, Plant and Equipment, Transfers and Changes USD 2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 118,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 43.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RestrictedCash Restricted Cash USD 4.91M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -216.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 89.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 89.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 11.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 50.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 8,945 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.59 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 18,955 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 4.18 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 15,922 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 104.67M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.39M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.23 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213424
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 86,064 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 8.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.89 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213424
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 216.67M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 8.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 8.07 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 216.67M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 8.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8.07 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.86 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 17 2026-04-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap ShortTermInvestments Short-term Investments USD 105.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StandardProductWarrantyAccrualPayments Standard Product Warranty Accrual, Decrease for Payments USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StandardProductWarrantyAccrualWarrantiesIssued Standard Product Warranty Accrual, Increase for Warranties Issued USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 103,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 303.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 303.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 12.94M 2026-04-20 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 235.00M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 197.84M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 270,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 235.00M 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 46.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 46.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-445905

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →